Studies have also shown an association between cerebrospinalfluid (CSF) biomarker and progression of cognitive impairment in PD, which mainly focus on Aβ 42, t-tau, p-tau, α-synuclein, and neurofilament light chain (NFL). The gene discussed is MAPT; the disease is Cognitive impairment.